Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.540
-0.050 (-3.14%)
At close: Dec 5, 2025, 4:00 PM EST
1.610
+0.070 (4.55%)
After-hours: Dec 5, 2025, 7:34 PM EST
Akebia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 409 | 415 | 234 | 106 | 395 | 405 | |
| Market Cap Growth | 4.07% | 77.46% | 120.08% | -73.16% | -2.30% | -46.16% | |
| Enterprise Value | 441 | 484 | 301 | 121 | 363 | 241 | |
| Last Close Price | 1.54 | 1.90 | 1.24 | 0.58 | 2.26 | 2.80 | |
| Forward PE | 78.97 | - | - | - | - | - | |
| PS Ratio | 1.68 | 2.59 | 1.20 | 0.36 | 1.87 | 1.37 | |
| PB Ratio | 9.82 | -8.43 | -7.64 | 20.30 | 5.34 | 1.63 | |
| P/TBV Ratio | - | - | - | - | - | 8.36 | |
| P/FCF Ratio | 12.70 | - | - | - | - | - | |
| P/OCF Ratio | 12.61 | - | - | - | - | - | |
| EV/Sales Ratio | 1.96 | 3.02 | 1.55 | 0.41 | 1.71 | 0.82 | |
| EV/EBITDA Ratio | 13.68 | - | - | 39.44 | - | - | |
| EV/FCF Ratio | 13.71 | - | - | - | - | - | |
| Debt / Equity Ratio | 4.79 | -3.84 | -4.72 | 30.07 | 2.56 | 0.51 | |
| Debt / EBITDA Ratio | 5.34 | - | - | 18.82 | - | - | |
| Asset Turnover | 0.79 | 0.69 | 0.65 | 0.66 | 0.36 | 0.42 | |
| Inventory Turnover | 1.92 | 1.64 | 2.13 | 0.77 | 1.67 | 0.72 | |
| Quick Ratio | 1.74 | 1.07 | 0.82 | 1.01 | 0.79 | 1.59 | |
| Current Ratio | 1.94 | 1.41 | 1.18 | 1.43 | 1.04 | 1.99 | |
| Return on Equity (ROE) | - | - | - | -237.83% | -175.37% | -119.82% | |
| Return on Assets (ROA) | 4.80% | -12.49% | -9.30% | -4.89% | -24.27% | -15.41% | |
| Return on Capital (ROIC) | 9.35% | -22.81% | -20.14% | -10.17% | -44.71% | -24.88% | |
| Return on Capital Employed (ROCE) | 9.50% | -33.10% | -31.40% | -15.30% | -84.90% | -38.20% | |
| Earnings Yield | -3.89% | -16.74% | -22.23% | -88.77% | -71.32% | -95.09% | |
| FCF Yield | 7.87% | -9.82% | -10.01% | -69.03% | -63.99% | -27.35% | |
| Buyback Yield / Dilution | -20.49% | -12.53% | -2.56% | -10.14% | -19.85% | -16.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.